CRWD vs MRK: Which Is the Better Buy?
Side-by-side comparison of CrowdStrike Holdings, Inc. and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-22.
CrowdStrike Holdings, Inc. · Technology
$449.61
+106.1% upside to fair value
Grade C
High Quality
VS
Merck & Co., Inc. · Healthcare
$119.07
-4.0% upside to fair value
Grade D
High Quality
QuantHub Verdict
CRWD has more upside to fair value
(+106.1%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
CRWD |
MRK |
| Current Price |
$449.61 |
$119.07 |
| Fair Value Estimate |
$926.44 |
$114.30 |
| Upside to Fair Value |
+106.1%
|
-4.0%
|
| Market Cap |
$114.0B |
$294.4B |
| Forward P/E |
-619.9x
|
16.2x
|
| EV / EBITDA |
981.7x
|
12.6x
|
| Price / Sales |
23.7x
|
4.5x
|
| Price / FCF |
92.0x
|
23.8x
|
| Revenue Growth YoY |
+23.3%
|
+5.0%
|
| Gross Margin |
74.9%
|
81.5%
|
| Operating Margin |
-5.4%
|
41.2%
|
| Return on Equity |
-4.7%
|
36.2%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
1.09%
|
4.2%
|
| Analyst Consensus |
Buy
|
Hold
|
Investment Thesis
CrowdStrike Holdings, Inc. is a leading cybersecurity company specializing in cloud-native endpoint protection and threat intelligence through its Falcon platform, which generates over 94% of its revenue from subscription services. The business quality is high due to its durable competitive moat built on cutting-edge big data security technology, strong management with a founder-led CEO who has o…
Merck & Co., Inc. is a leading global healthcare company specializing in pharmaceuticals, particularly oncology and vaccines. The company benefits from a strong business quality characterized by a durable competitive moat, high gross margins of 81.5%, and a robust return on equity of 36.2%. Despite these strengths, the stock is currently fairly valued but slightly overvalued by 4% relative to its…
Accumulation Zones
| Metric |
CRWD |
MRK |
| Zone Low |
$694.83 |
$85.72 |
| Zone High |
$787.47 |
$97.16 |
| In Buy Zone? |
Yes
|
No
|